BioMarin Pharmaceutical Inc. Financial Ratios — BMRN Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-7.22	-12.78	-14.97	-9.34	-8.75	-24.39	-4.2	-2.67	-0.78	23.63	-1.53	3.19	3.51	8.05	5.94
Return on Assets (%)	-4.19	-7.96	-9.25	-5.68	-5.54	-16.26	-2.7	-1.7	-0.52	16.21	-1.08	2.29	2.54	6.17	4.79
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.8	3.12	7.1	5.51
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.98	2.81	6.06	4.57
Gross Margin (%)	80.96	81.66	83.88	83.68	82.92	81.23	81.59	78.86	78.91	71.82	74.52	76	78.01	79.67	77.73
EBITDA Margin (%)	0.26	-13.16	-21.71	-15.28	-26.33	-9.62	-3.95	-3.98	0.03	0.72	1.83	7.6	11.99	20	15.18
Operating Margin (%)	-7.68	-22.01	-28.27	-21.41	-31.63	-18.29	-10.63	-10.4	-6.15	-4.94	-4.03	2.74	7.68	16.62	12.71
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	52.75	39.72	66.36	-17.63
Pretax Margin (%)	-9.88	-23.62	-32.18	-16.66	-17.39	-74.41	-2.73	-9.57	-5.56	-2.63	-4.08	7.14	7.79	18.98	14.98
Profit Margin (%)	-12.2	-22.84	-32.15	-17.88	-19.31	-56.43	-8.91	-5.18	-1.4	45.9	-3.47	6.75	6.93	14.96	10.83
Net Income to Common Margin (%)	-12.2	-22.84	-32.15	-17.88	-19.31	-56.43	-8.91	-5.18	-1.4	45.9	-3.47	6.75	6.93	14.96	10.83
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.36	11.09	21.21	27.69
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-7.22	-12.78	-14.97	-9.34	-8.75	-24.39	-4.2	-2.67	-0.78	23.63	-1.53	3.19	3.51	8.05	5.94

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	348	348	656	643	662	683	1,174	830	859	1,087	1,090	1,093	1,096	603	606
ST Debt	- -	23	- -	- -	- -	22	361	- -	373	12	10	10	503	8	9
LT Debt	348	325	656	643	662	661	814	830	486	1,075	1,079	1,083	593	595	597
Total Debt/EBITDA	301.32	-5.29	-5.51	-5.61	-2.83	-6.36	-22.66	-13.99	1,808.04	81.48	32.32	6.86	3.78	1.06	1.24
Net Debt/EBITDA	261.29	-2.55	-0.73	2.03	-1.13	-2.56	-11.12	-5.67	864.58	31.94	14.59	2.25	1.14	-0.61	-1.46
Total Debt/EBIT	-10.28	-3.16	-4.23	-4.01	-2.35	-3.34	-8.41	-5.36	-8.19	-11.84	-14.66	19.05	5.9	1.27	1.48
Net Debt/EBIT	-8.91	-1.52	-0.56	1.45	-0.94	-1.35	-4.13	-2.17	-3.92	-4.64	-6.62	6.24	1.79	-0.73	-1.74
EBITDA to Interest Expense	0.14	-9.86	-12.7	-3.44	-6.7	-2.97	-1.33	-1.36	0.02	0.49	2.29	11.54	16.74	45.05	44.87
EBITDA-CapEx/Interest Expense	-18.2	-16.54	-19.66	-6.95	-13.22	-7.08	-6.44	-4.67	-7.6	-4.52	-5.8	2.02	10.53	37.36	34.69
EBIT to Interest Expense	-4.03	-16.5	-16.55	-4.82	-8.05	-5.65	-3.58	-3.55	-4.89	-3.34	-5.04	4.16	10.72	37.44	37.57
Interest Expense	8	7	9	33	35	36	39	44	21	27	15	14	17	13	11
Common Equity/Total Assets	59.21	64.77	59.76	61.72	64.38	68.75	60.62	67.04	66.57	70.21	71.04	72.21	72.37	80.96	80.16
Long-Term Debt/Equity (%)	45.06	31.98	48.88	42.08	27.59	23.89	28.96	27.98	15.57	26.18	25.3	23.53	11.98	10.52	9.81
Long-Term Debt/Capital (%)	31.06	23.82	32.83	29.62	21.62	19.16	20.42	21.86	12.21	20.7	20.15	19.01	9.81	9.51	8.92
Long-Term Debt/Total Assets (%)	26.68	20.71	29.21	25.97	17.76	16.42	17.56	18.76	10.37	18.38	17.97	16.99	8.67	8.52	7.86
Total Debt/Equity (%)	45.06	34.28	48.88	42.08	27.59	24.7	41.82	27.98	27.51	26.47	25.54	23.75	22.13	10.65	9.95
Total Debt/Capital (%)	31.06	25.53	32.83	29.62	21.62	19.81	29.49	21.86	21.57	20.93	20.35	19.19	18.12	9.63	9.05
Total Debt/Total Assets (%)	26.68	22.2	29.21	25.97	17.76	16.98	25.35	18.76	18.31	18.59	18.14	17.15	16.02	8.62	7.98
Net Debt to Equity	39.07	16.51	6.47	-15.22	11.05	9.94	20.52	11.34	13.15	10.37	11.53	7.79	6.7	-6.15	-11.74
Net Debt/Capital (%)	28.1	14.17	6.08	-17.96	9.95	9.04	17.03	10.18	11.59	9.38	10.31	7.21	6.27	-6.54	-13.28
EBITDA	1	-66	-119	-115	-234	-107	-52	-59	- -	13	34	159	290	571	489
EBITDA-CapEx	-153	-110	-184	-232	-462	-256	-251	-204	-163	-124	-86	28	183	473	378
Operating Income (Loss)	-34	-110	-155	-160	-282	-204	-140	-155	-105	-92	-74	57	186	474	409

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.07	2.63	4.28	4.01	1.33	1.8	1.71	2.07	0.81	2.16	1.86	2.19	0.91	1.87	2.06
Current Ratio	4.99	4.36	6.21	5.93	2.45	3.24	2.7	3.93	2.08	4.76	4.16	4.67	2.51	5.33	5.21
Quick Ratio	3.19	3.27	4.99	4.86	1.7	2.29	2.03	2.73	1.21	3.07	2.54	2.98	1.45	2.96	3.25
CFO/Avg Current Liab	0.21	0.13	-0.32	-0.34	-0.64	-0.52	-0.01	0.03	0.07	0.12	0.59	0.31	0.18	0.64	1.21
Common Equity/Total Assets	59.21	64.77	59.76	61.72	64.38	68.75	60.62	67.04	66.57	70.21	71.04	72.21	72.37	80.96	80.16
Long-Term Debt/Equity (%)	45.06	31.98	48.88	42.08	27.59	23.89	28.96	27.98	15.57	26.18	25.3	23.53	11.98	10.52	9.81
Long-Term Debt/Capital (%)	31.06	23.82	32.83	29.62	21.62	19.16	20.42	21.86	12.21	20.7	20.15	19.01	9.81	9.51	8.92
Long-Term Debt/Total Assets (%)	26.68	20.71	29.21	25.97	17.76	16.42	17.56	18.76	10.37	18.38	17.97	16.99	8.67	8.52	7.86
Total Debt/Equity (%)	45.06	34.28	48.88	42.08	27.59	24.7	41.82	27.98	27.51	26.47	25.54	23.75	22.13	10.65	9.95
Total Debt/Capital (%)	31.06	25.53	32.83	29.62	21.62	19.81	29.49	21.86	21.57	20.93	20.35	19.19	18.12	9.63	9.05
Total Debt/Total Assets (%)	26.68	22.2	29.21	25.97	17.76	16.98	25.35	18.76	18.31	18.59	18.14	17.15	16.02	8.62	7.98
CFO/Total Liabilities	3.46	3.19	-6.35	-7.43	-16.52	-18.12	-0.48	1.38	3.08	4.9	17.51	9.93	8.43	43.04	54.94
CFO/CapEx	0.12	0.4	-0.88	-0.6	-0.96	-1.54	-0.04	0.14	0.3	0.62	2.55	1.34	1.48	5.88	7.46
Altman's Z-Score	4.62	6.77	6.79	8.72	7.4	6.67	5.21	6.36	5.86	5.98	6.04	7.17	6.45	6.77	5.75

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	4.61	4.68	4.83	5.71	5.75	5.87	5.51	4.94	4.73	4.51	4.49	5.02	4.42	4.41	4.11
Days Sales Outstanding	79.15	77.96	75.49	63.89	63.46	62.13	66.22	73.92	77.11	81	81.23	72.68	82.61	82.76	88.88
Inventory Turnover	0.7	0.71	0.61	0.68	0.65	0.67	0.58	0.63	0.59	0.76	0.64	0.6	0.53	0.5	0.57
Days Inventory Outstanding	520.89	514.36	601.44	540.42	565.64	545.71	627.16	582.73	614.9	479.97	572.2	606.16	686.44	735.94	643.96
Accounts Payable Turnover	5.09	1.75	1.51	1.36	1.41	1.58	2.02	1.98	2.27	2.51	2.81	2.88	2.73	2.56	2.86
Accounts Payable Turnover Days	71.72	208.4	242.41	269.33	259.47	230.81	180.25	184.41	160.89	145.45	130.1	126.75	133.91	142.47	127.66
Cash Conversion Cycle	528.32	383.92	434.53	334.98	369.63	377.03	513.13	472.23	531.13	415.52	523.33	552.08	635.14	676.24	605.18
Inventory to Cash Days	-441.74	-436.39	-525.95	-476.53	-502.18	-483.58	-560.95	-508.81	-537.78	-398.97	-490.97	-533.48	-603.84	-653.18	-555.08
Inventories	130	129	163	199	272	355	476	531	680	699	777	894	1,107	1,233	1,299
Raw Materials	12	12	15	22	46	51	50	75	74	77	80	131	156	154	107
Work In Process	76	71	88	114	150	168	235	231	350	308	415	411	571	551	801
Finished Goods	42	45	59	63	75	136	191	225	256	314	281	352	380	528	391
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	3,946	6,190	10,093	13,478	16,921	14,302	15,680	15,178	15,205	15,937	16,249	19,275	18,185	12,539	11,428
- Cash & Cash Equivalents	46	181	569	875	397	408	598	494	437	649	587	725	755	943	1,312
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	348	348	656	643	662	683	1,174	830	859	1,087	1,090	1,093	1,096	603	606
Enterprise Value	4,100	6,090	9,964	13,176	16,991	14,196	15,458	14,924	15,310	15,958	16,324	19,077	18,207	12,004	10,474
Total Capital	1,121	1,364	1,997	2,171	3,063	3,450	3,983	3,798	3,981	5,193	5,355	5,697	6,047	6,261	6,693
Total Debt/Capital (%)	31.06	25.53	32.83	29.62	21.62	19.81	29.49	21.86	21.57	20.93	20.35	19.19	18.12	9.63	9.05
Total Debt / EV	0.08	0.06	0.07	0.05	0.04	0.05	0.08	0.06	0.06	0.07	0.07	0.06	0.06	0.05	0.06
EV/Sales	9.29	12.16	18.17	17.58	19.09	12.71	11.77	10.01	8.98	8.58	8.84	9.1	7.53	4.21	3.25
EV/EBITDA	3,546.46	- -	- -	- -	- -	- -	- -	- -	32,232.26	1,196.37	484.32	119.7	62.75	21.03	21.42
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	332.29	98	25.31	25.58
EV/Cash Flow to Firm	142.39	253.06	- -	- -	- -	- -	130.54	340.49	285.36	- -	51.48	100.95	104.23	20.6	12.53
EV/Free Cash Flow to Firm	22.4	88.73	578.57	159.94	361.81	- -	48.67	79.19	70.54	- -	37.42	59.52	64.5	17.65	11.06
Diluted Market Cap	3,855	5,917	9,691	13,230	16,764	13,770	15,554	15,094	15,138	16,808	16,155	19,556	18,474	12,930	11,731
Diluted Enterprise Value	4,157	6,085	9,778	12,997	17,029	14,044	16,130	15,431	15,559	17,246	16,657	19,925	18,814	12,589	11,025
EV per Share	35.71	48.41	69.45	88.37	105.19	82.22	87.91	83.73	85.13	87.81	88.76	102.43	96.54	62.93	54.47
TTM Sales	441	501	548	749	890	1,117	1,314	1,491	1,704	1,860	1,846	2,096	2,419	2,854	3,221
TTM EBITDA	1	-66	-119	-115	-234	-107	-52	-59	- -	13	34	159	290	571	489
TTM Operating Income	-34	-110	-155	-160	-282	-204	-140	-155	-105	-92	-74	57	186	474	409
TTM Cash Flow to Firm	29	24	-48	-35	-181	-200	118	44	54	-394	317	189	175	583	836
TTM Free Cash Flow to Firm	183	69	17	82	47	-52	318	188	217	-256	436	321	282	680	947

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	22.33	95.16	1,233.27	283.66	2,055.95	-173.3	81.66	91.58	71.52	75.41	38.12	63.61	69.22	19.29	12.49
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	332.29	98	25.31	25.58
Enterprise Value	4,100	6,090	9,964	13,176	16,991	14,196	15,458	14,924	15,310	15,958	16,324	19,077	18,207	12,004	10,474
Low Price	23.09	31.91	49.71	55.04	88.51	62.12	80.1	75.81	62.88	68.25	71.59	70.73	76.02	61.15	50.76
EV/Sales	9.29	12.16	18.17	17.58	19.09	12.71	11.77	10.01	8.98	8.58	8.84	9.1	7.53	4.21	3.25
EV/EBITDA	3,546.46	- -	- -	- -	- -	- -	- -	- -	32,232.26	1,196.37	484.32	119.7	62.75	21.03	21.42
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.56	- -	135.44	108.03	29.26	32.67
Price/Earnings Average	-59.19	-41.17	-49.54	-77.29	-109.1	-22.84	-132.36	-211.24	-619.86	19.37	-229.95	113.34	105.06	35.94	32.61
Price/Earnings High	-74.06	-55.7	-63.01	-105.26	-141.35	-27.82	-149.79	-244.78	-751.73	27.93	-263.09	143.39	131.95	44.18	40.41
Price/Earnings Low	-48.09	-33.56	-38.83	-60.13	-82.44	-16.36	-119.37	-173.85	-472.07	14.45	-204.28	92.57	85.17	27.22	27.9
Price/Book Value	5.11	6.09	7.53	8.82	7.05	5.17	5.58	5.11	4.87	3.88	3.81	4.19	3.67	2.22	1.88
Price/Book Value Average	4.22	4.85	6.78	6.9	7.88	5.41	5.56	5.53	4.76	4.05	3.47	3.5	3.57	2.72	1.87
Price/Book Value High	5.28	6.56	8.63	9.4	10.21	6.59	6.29	6.41	5.77	5.84	3.98	4.43	4.49	3.35	2.32
Price/Book Value Low	3.43	3.95	5.32	5.37	5.95	3.88	5.01	4.55	3.62	3.02	3.09	2.86	2.9	2.06	1.6
Price/Tangible Book Value	7.29	7.73	8.98	10.23	11.13	7.1	7.49	6.66	6.16	4.56	4.41	4.74	4.08	2.41	2.01
Price/Tangible Book Value Average	6.03	6.15	8.1	8.01	12.45	7.43	7.46	7.2	6.01	4.76	4.03	3.96	3.96	2.96	2.01
Price/Tangible Book Value High	7.54	8.32	10.3	10.91	16.13	9.05	8.44	8.35	7.29	6.87	4.61	5.02	4.98	3.64	2.49
Price/Tangible Book Value Low	4.9	5.01	6.35	6.23	9.41	5.32	6.73	5.93	4.58	3.55	3.58	3.24	3.21	2.24	1.72
Price/Sales	8.73	11.82	17.67	17.66	18.84	12.31	11.84	10.11	8.88	8.52	8.75	9.15	7.49	4.38	3.54
Price/Sales Average	7.22	9.4	15.93	13.82	21.06	12.89	11.79	10.94	8.67	8.89	7.98	7.65	7.28	5.37	3.53
Price/Sales High	9.03	12.72	20.26	18.82	27.29	15.7	13.35	12.67	10.52	12.82	9.13	9.68	9.14	6.61	4.38
Price/Sales Low	5.87	7.66	12.48	10.75	15.92	9.23	10.64	9	6.61	6.63	7.09	6.25	5.9	4.07	3.02
Price/Cash Flow	209.33	336.04	-169.03	-187.87	-76.37	-60.35	-1,776.14	746.08	313.66	185.73	53.05	109	113.72	21.8	13.77
Price/Cash Flow Average	173.03	267.34	-152.37	-147.04	-85.39	-63.16	-1,769.05	807.12	306.29	193.83	48.39	91.21	110.59	26.78	13.74
Price/Cash Flow High	216.51	361.72	-193.82	-200.25	-110.63	-76.94	-2,002.02	935.25	371.46	279.47	55.36	115.39	138.9	32.92	17.03
Price/Cash Flow Low	140.59	217.95	-119.43	-114.38	-64.53	-45.26	-1,595.48	664.24	233.27	144.55	42.98	74.5	89.66	20.29	11.76
Price/Free Cash Flow Average	18.46	75.71	1,111.76	222.01	2,298.56	-181.37	81.34	99.07	69.84	78.7	34.77	53.23	67.32	23.69	12.47
Price/Free Cash Flow High	23.1	102.44	1,414.19	302.36	2,978.14	-220.93	92.05	114.8	84.69	113.48	39.78	67.34	84.55	29.13	15.45
Price/Free Cash Flow Low	15	61.72	871.44	172.71	1,737.04	-129.95	73.36	81.53	53.19	58.69	30.89	43.47	54.58	17.95	10.67
EV/Sales Average	8.08	10.17	16.75	13.77	21.56	13.65	12.33	11.24	8.96	9.17	8.3	7.87	7.45	5.28	3.32
EV/Sales High	9.93	13.64	21.26	18.86	27.84	16.57	13.89	12.98	10.81	13.12	9.46	9.91	9.32	6.51	4.17
EV/Sales Low	6.69	8.35	13.16	10.64	16.36	9.85	11.16	9.29	6.88	6.9	7.4	6.46	6.07	3.97	2.81
EV/EBITDA Average	3,083.22	-77.29	-77.15	-90.08	-81.87	-141.93	-312.39	-282.26	32,146.86	1,279.67	454.61	103.52	62.12	26.39	21.88
EV/EBITDA High	3,792.37	-103.68	-97.94	-123.42	-105.74	-172.33	-352.06	-326.17	38,796.98	1,830.61	517.98	130.35	77.72	32.58	27.46
EV/EBITDA Low	2,554.11	-63.48	-60.63	-69.63	-62.15	-102.42	-282.83	-233.3	24,693.88	962.71	405.52	84.97	50.58	19.85	18.52
EV/EBIT Average	-105.17	-46.2	-59.23	-64.32	-68.15	-74.61	-115.92	-108.08	-145.67	-185.88	-206.14	287.38	97.02	31.75	26.14
EV/EBIT High	-129.36	-61.97	-75.19	-88.12	-88.02	-90.59	-130.64	-124.89	-175.8	-265.9	-234.88	361.86	121.39	39.21	32.8
EV/EBIT Low	-87.12	-37.95	-46.55	-49.71	-51.73	-53.84	-104.95	-89.33	-111.9	-139.84	-183.88	235.89	79.01	23.88	22.11
Last Price	34.38	49.2	70.35	90.4	104.76	82.84	89.17	85.15	84.55	87.69	88.35	103.49	96.42	65.73	59.43
High Price	35.56	52.96	80.67	96.36	151.75	105.61	100.51	106.74	100.13	131.95	92.2	109.56	117.77	99.25	73.51
Enterprise Value Average	3,564	5,092	9,185	10,316	19,184	15,243	16,194	16,756	15,270	17,069	15,323	16,498	18,024	15,059	10,703
Enterprise Value High	4,384	6,831	11,660	14,134	24,777	18,508	18,250	19,363	18,429	24,418	17,459	20,774	22,552	18,593	13,430
Enterprise Value Low	2,953	4,182	7,218	7,974	14,562	11,000	14,662	13,850	11,730	12,842	13,669	13,542	14,678	11,325	9,055

Shares Outstanding	115	126	143	149	162	173	176	178	180	182	184	186	189	191	192
Diluted Weighted Avg Shares	112	120	138	146	160	166	174	177	179	192	183	189	192	197	197
Basic Weighted Avg Shares	112	120	138	146	160	166	174	177	179	181	183	185	188	190	192
Revenue per Share	3.94	4.16	3.98	5.12	5.56	6.73	7.53	8.42	9.52	10.29	10.1	11.31	12.88	15.02	16.8
EBITDA per Share	0.01	-0.55	-0.86	-0.78	-1.46	-0.65	-0.3	-0.34	- -	0.07	0.18	0.86	1.54	3	2.55
Operating Income per Share	-0.3	-0.92	-1.13	-1.1	-1.76	-1.23	-0.8	-0.88	-0.59	-0.51	-0.41	0.31	0.99	2.5	2.14
Basic EPS, GAAP	-0.48	-0.95	-1.28	-0.92	-1.07	-3.8	-0.67	-0.44	-0.13	4.72	-0.35	0.76	0.89	2.25	1.82
Basic EPS from Cont Ops	-0.48	-0.95	-1.28	-0.92	-1.07	-3.8	-0.67	-0.44	-0.13	4.72	-0.35	0.76	0.89	2.25	1.82
Diluted EPS, GAAP	-0.48	-0.95	-1.28	-0.92	-1.07	-3.79	-0.67	-0.44	-0.13	4.46	-0.35	0.75	0.87	2.17	1.77
Diluted EPS from Cont Ops	-0.48	-0.95	-1.28	-0.92	-1.07	-3.79	-0.67	-0.44	-0.13	4.46	-0.35	0.75	0.87	2.17	1.77
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.16	0.15	-0.42	-0.48	-1.37	-1.37	-0.05	0.11	0.27	0.47	1.67	0.95	0.85	3.01	4.32
Free Cash Flow per Basic Share	-1.21	-0.22	-0.89	-1.28	-2.79	-2.27	-1.19	-0.7	-0.64	-0.29	1.01	0.24	0.27	2.5	3.74
Cash & Equivalents per Share	1.7	3.56	5.47	6.34	3.67	4.57	7.94	6.08	4.19	5.86	5.51	6.93	5.69	5.96	8.12
Book Value per Share	6.73	8.07	9.35	10.25	14.86	16.02	15.97	16.65	17.36	22.59	23.19	24.71	26.25	29.66	31.65
Tangible Book Value per Share	4.71	6.37	7.83	8.83	9.41	11.67	11.91	12.79	13.73	19.22	20.01	21.84	23.65	27.29	29.52

BioMarin Pharmaceutical Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)